{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:42:25Z","timestamp":1790214145270,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Tubulocystic renal cell carcinoma is a rare neoplasm, first adopted into the WHO classification of kidney tumors in 2016. The diagnostic criteria were refined in the 2022 WHO classification, requiring \u201cpure morphology\u201d and exclusion of other renal cell carcinoma subtypes with overlapping features. We identified 31 tubulocystic renal cell carcinomas from 30 patients. Median age was 60 years (30 to 77\u00a0y) with male:female ratio of 13.5:1. Race was known for 26 patients, and the majority were African American (n = 16\/26,62%), followed by white\/Caucasian (10\/26, 38%). Eleven patients (37%) had a history of chronic or end-stage renal disease. Median tumor size was 2.3\u00a0cm (range: 0.4 to 6.3\u00a0cm). All tumors were characterized by cysts and tubules, surrounded by fibrotic stroma. Lining epithelial cells had eosinophilic cytoplasm, ranging from flattened to cuboidal to hobnail in arrangement. By definition, solid epithelial nodules and destructive invasion were absent. In addition, all tumors had a normal pattern of FH and 2SC expression by immunohistochemistry. AJCC stage was pT1 for all 31 tumors: 30 pT1a and 1 pT1b. All patients had no evidence of disease at last follow-up (median: 35\u00a0mo; range: 1 to 294\u00a0mo). We report a large series of tubulocystic renal cell carcinomas with pure morphology and confirmed normal\/\u201cwild type\u201d FH\/2SC immunophenotype. When these strict definitions are applied, our findings confirm an indolent clinical behavior.<\/jats:p>","DOI":"10.1097\/pas.0000000000002457","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T13:00:35Z","timestamp":1753794035000},"page":"1225-1232","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Tubulocystic Renal Cell Carcinoma With Pure Morphology and Confirmed \u201cWild Type\u201d FH\/2SC Immunophenotype"],"prefix":"10.1097","volume":"49","author":[{"given":"Lara R.","family":"Harik","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University School of Medicine"},{"name":"Winship Cancer Institute, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Magi-Galluzzi","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Manucha","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Mississippi Medical Center, Jackson, MS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Wobker","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur R.","family":"Sangoi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha","family":"Jagannathan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Saeed","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University School of Medicine"},{"name":"Winship Cancer Institute, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin S.","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University School of Medicine"},{"name":"Winship Cancer Institute, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti","family":"Lal","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Pennsylvania, Pennsylvania, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"O\u2019Toole","sequence":"additional","affiliation":[{"name":"Department of Pathology, Columbia University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse K.","family":"McKenney","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"R5-20251112","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0090-4295(97)00335-X","article-title":"Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin","volume":"50","author":"MacLennan","year":"1997","journal-title":"Urology"},{"key":"R6-20251112","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/PAS.0b013e318150df1d","article-title":"Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization","volume":"32","author":"Yang","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R7-20251112","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/PAS.0b013e3181872d3f","article-title":"Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma","volume":"33","author":"Amin","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R8-20251112","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1097\/PAS.0b013e3181be22d1","article-title":"Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification","volume":"33","author":"Zhou","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R9-20251112","first-page":"1452","article-title":"Renal cell carcinomas with t(6;11)(p21;q12) presenting with tubulocystic renal cell carcinoma-like features","volume":"6","author":"Rao","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"R10-20251112","first-page":"155","article-title":"Rethinking about tubulocystic carcinoma of the kidney after taking into account the existence of tubulocystic chromophobe renal carcinoma","volume":"30","author":"Baydar","year":"2014","journal-title":"Turk Patoloji Derg"},{"key":"R11-20251112","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000719","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma","volume":"40","author":"Smith","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R12-20251112","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/jclinpath-2019-205924","article-title":"Fumaratehydratase-deficient renal cell carcinoma: a clinicopathological and molecular study of 13 cases","volume":"72","author":"Pan","year":"2019","journal-title":"J Clin Pathol"},{"key":"R13-20251112","doi-asserted-by":"crossref","first-page":"151599","DOI":"10.1016\/j.anndiagpath.2020.151599","article-title":"Fumarate hydratase-deficient renal cell carcinoma: a clinicopathological study of seven cases including hereditary and sporadic forms","volume":"49","author":"Kuroda","year":"2020","journal-title":"Ann Diagn Pathol"},{"key":"R14-20251112","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/PAS.0000000000001091","article-title":"Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): a multiinstitutional study of 40 cases with clinical follow-up","volume":"42","author":"Przybycin","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R15-20251112","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.humpath.2024.06.002","article-title":"Acquired cystic disease associated renal cell carcinoma: a clinicopathologic and molecular study of 31 tumors","volume":"149","author":"Palathingal Bava","year":"2024","journal-title":"Hum Pathol"},{"key":"R16-20251112","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.humpath.2012.11.015","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: a series of 3 cases with fluorescence in situ hybridization analysis","volume":"44","author":"Al-Hussain","year":"2013","journal-title":"Hum Pathol"},{"key":"R17-20251112","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"key":"R19-20251112","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00428-007-0483-7","article-title":"Tubulocystic carcinoma of the kidney: a new entity among renal tumors","volume":"451","author":"Azoulay","year":"2007","journal-title":"Virchows Arch"},{"key":"R20-20251112","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/PAS.0b013e3181a13e7b","article-title":"Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney","volume":"33","author":"Osunkoya","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R21-20251112","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41379-018-0185-5","article-title":"Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile","volume":"32","author":"Sarungbam","year":"2019","journal-title":"Mod Pathol"},{"key":"R23-20251112","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cll.2005.01.005","article-title":"Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumors","volume":"25","author":"MacLennan","year":"2005","journal-title":"Clin Lab Med"},{"key":"R24-20251112","first-page":"137A","article-title":"Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 29 cases of a distinctive rare subtype of renal carcinoma","volume":"17","author":"Amin","year":"2004","journal-title":"Mod Pathol"},{"key":"R25-20251112","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PAP.0000000000000341","article-title":"Updates in grading of renal cell carcinomas beyond clear cell renal cell carcinoma and papillary renal cell carcinoma","volume":"29","author":"Paner","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"R26-20251112","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","article-title":"Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status","volume":"225","author":"Bardella","year":"2011","journal-title":"J Pathol"},{"key":"R27-20251112","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R28-20251112","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41379-018-0017-7","article-title":"Pattern multiplicity and fumarate hydratase (FH)\/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration","volume":"31","author":"Muller","year":"2018","journal-title":"Mod Pathol"},{"key":"R29-20251112","first-page":"e74015","article-title":"Clinicopathologic Study of 28 cases of tubulocystic renal cell carcinoma: is it time to reclassify it as a tubulocystic renal cell tumor?","volume":"16","author":"Xiao","year":"2024","journal-title":"Cureus"},{"key":"R30-20251112","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/0391560319870091","article-title":"A simple cyst is not always simply a cyst: a case of cystic recurrence after nephrectomy for tubulocystic renal cell carcinoma and literature review","volume":"87","author":"Salvatori","year":"2020","journal-title":"Urologia"},{"key":"R31-20251112","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2011.01.038","article-title":"Unique case of tubulocystic carcinoma of the kidney with sarcomatoid features: a new entity","volume":"78","author":"Bhullar","year":"2011","journal-title":"Urology"},{"key":"R32-20251112","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/medicina57080851","article-title":"Tubulocystic renal cell carcinoma is not an indolent tumor: a case report of recurrences in the retroperitoneum and contralateral kidney","volume":"57","author":"Choi","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"R33-20251112","first-page":"e12117","article-title":"Rarest of the rare metastatic tubulocystic carcinoma of kidney","volume":"12","author":"Yousuf","year":"2020","journal-title":"Cureus"},{"key":"R34-20251112","first-page":"11124","article-title":"Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature","volume":"8","author":"Zhao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R35-20251112","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11604-016-0525-7","article-title":"A case of tubulocystic carcinoma of the kidney with aggressive features","volume":"34","author":"Maeda","year":"2016","journal-title":"Jpn J Radiol"},{"key":"R36-20251112","first-page":"641","article-title":"Type 2 and clear cell papillary renal cell carcinoma, and tubulocystic carcinoma: a unifying concept","volume":"30","author":"Brennan","year":"2010","journal-title":"Anticancer Res"},{"key":"R37-20251112","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.4081\/rt.2013.e57","article-title":"Bilateral tubulocystic renal cell carcinomas in diabetic end-stage renal disease: first case report with cytogenetic and ultrastructural studies","volume":"5","author":"Kong","year":"2013","journal-title":"Rare Tumors"},{"key":"R38-20251112","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N Engl J Med"},{"key":"R39-20251112","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/PAS.0000000000000733","article-title":"Mixed epithelial and stromal tumor of the kidney: a clinicopathologic study of 53 cases","volume":"40","author":"Cali\u00f2","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R40-20251112","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.pas.0000185382.80844.b1","article-title":"Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia","volume":"30","author":"Tickoo","year":"2006","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:00:30Z","timestamp":1762927230000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002457"}},"subtitle":["Clinicopathologic Series of 30 Patients"],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002457","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]}}}